Shuji Horinouchi

Statistics

Publications

Citations

472

H-Index

Active since

2006

Affiliations

Richard L. Roudebush VA Medical Center(Current)

German Centre for Cardiovascular Research

University of Chicago

Universidad Europea de Madrid

Steno Diabetes Centers

Shuji Horinouchi is an author at Richard L. Roudebush VA Medical Center specializing in medicine, renal pharmacotherapy, and glomerular filtration rate measurement.

Publications per year

2006–2023

Publications

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

Rajiv Agarwal, Wanzhu Tu, Alfredo E. Farjat et al. · Annals of Internal Medicine · 2023 · 88 citations

Medicine, Pharmacology, Pharmacotherapy +17

Serum VEGF—As a prognostic factor of atherosclerosis

Kuriko Kimura, Teruto Hashiguchi, Takahisa Deguchi et al. · Atherosclerosis · 2006 · 78 citations

Veterinary Medicine, Pathobiology, Pathology +13

Serum VEGF increases in diabetic polyneuropathy, particularly in the neurologically active symptomatic stage

Takahisa Deguchi, Teruto Hashiguchi, Shuji Horinouchi et al. · Diabetic Medicine · 2009 · 52 citations

Medicine, Endocrinology, Neurology +13

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

Ellen Burgess, Rajiv Agarwal, Stefan D. Anker et al. · Diabetes Care · 2022 · 35 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

1–5 of 6